Wolverine Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,166
Closed -$272K 5508
2023
Q4
$272K Buy
+9,166
New +$183K ﹤0.01% 3563
2021
Q3
Sell
-10,165
Closed -$58.7K 7187
2021
Q2
$67K Buy
+10,165
New +$70.9K ﹤0.01% 5548
2020
Q3
Sell
-16,112
Closed -$65.1K 5324
2020
Q2
$70K Buy
16,112
+1,589
+11% +$6.76K ﹤0.01% 4241
2020
Q1
$52K Buy
+14,523
New +$63.5K ﹤0.01% 4254
2019
Q4
Sell
-33,760
Closed -$115K 5376
2019
Q3
$92K Buy
33,760
+9,853
+41% +$26.2K ﹤0.01% 3875
2019
Q2
$52K Sell
23,907
-35,133
-60% -$83.1K ﹤0.01% 4185
2019
Q1
$160K Buy
59,040
+29,271
+98% +$127K ﹤0.01% 3959
2018
Q4
$134K Sell
29,769
-1,231
-4% -$7.47K ﹤0.01% 3871
2018
Q3
$294K Buy
+31,000
New +$298K ﹤0.01% 3756
2018
Q1
Sell
-29,229
Closed -$187K 6014
2017
Q4
$187K Sell
29,229
-22,836
-44% -$141K ﹤0.01% 4202
2017
Q3
$398K Buy
52,065
+33,033
+174% +$219K ﹤0.01% 2899
2017
Q2
$137K Buy
+19,032
New +$87.1K ﹤0.01% 3790

Other funds holding IMGN

Wolverine Trading's IMGN Position: Q1 2024 in Review

Wolverine Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 9,166 shares — an estimated $272K sold.

Wolverine Trading first reported a position in IMGN in Q2 2017 and held it in 12 quarters. The position peaked at $398K in Q3 2017. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Wolverine Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Wolverine Trading sold 9,166 Immunogen Inc shares in Q1 2024, an estimated $272K.
  • Wolverine Trading first reported a position in Immunogen Inc in Q2 2017 and held it in 12 quarters.
  • Wolverine Trading's Immunogen Inc position peaked at $398K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Wolverine Trading's 13F filing for Q1 2024, filed 15 May 2024.